Picture of COSCIENS Biopharma logo

CSCI — COSCIENS Biopharma News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Aeterna Zentaris Qtrly Loss Per Common Share $0.30

May 7 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS REPORTS FIRST QUARTER 2019 FINANCIAL AND
OPERATING RESULTS
    * QTRLY  LOSS PER COMMON SHARE $0.30
    * Q1 LOSS PER SHARE $0.30
    * AS OF MARCH 31, 2019, CO HAD $11.4 MILLION OF UNRESTRICTED
CASH
AND CASH EQUIVALENTS

Source text for Eikon:  ID:nGNX9tZv5T 
Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on COSCIENS Biopharma

See all news